Hikma Pharmaceuticals agrees to acquire Medlac Pharma, an injectable manufacturing company in Vietnam
Deal terms were not disclosed
Riad Mechlaoui, President of Injectables, commented, “I’m very pleased to have reached agreement to acquire Medlac. Vietnam is an attractive market with significant growth potential. We are confident that by leveraging Hikma’s global expertise, we can add significant value to Medlac’s business.”
Date: November 12, 2018
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Source: Seeking Alpha